Menu
GeneBe

15-71827917-T-C

Variant summary

Our verdict is Likely benign. Variant got -3 ACMG points: 2P and 5B. PM2BP4_StrongBP6

The NM_006901.4(MYO9A):ā€‹c.7150A>Gā€‹(p.Met2384Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000127 in 1,613,802 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: š‘“ 0.00060 ( 0 hom., cov: 32)
Exomes š‘“: 0.000078 ( 0 hom. )

Consequence

MYO9A
NM_006901.4 missense

Scores

18

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:1

Conservation

PhyloP100: 0.266
Variant links:
Genes affected
MYO9A (HGNC:7608): (myosin IXA) This gene encodes a member of the myosin superfamily. The protein represents an unconventional myosin; it should not be confused with the conventional non-muscle myosin-9 (MYH9). Unconventional myosins contain the basic domains of conventional myosins and are further distinguished from class members by their tail domains. They function as actin-based molecular motors. Mutations in this gene have been associated with Bardet-Biedl Syndrome. [provided by RefSeq, Dec 2011]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -3 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.0027232468).
BP6
Variant 15-71827917-T-C is Benign according to our data. Variant chr15-71827917-T-C is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 757414.We mark this variant Likely_benign, oryginal submissions are: {Uncertain_significance=1, Likely_benign=1}.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
MYO9ANM_006901.4 linkuse as main transcriptc.7150A>G p.Met2384Val missense_variant 41/42 ENST00000356056.10

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
MYO9AENST00000356056.10 linkuse as main transcriptc.7150A>G p.Met2384Val missense_variant 41/421 NM_006901.4 P2B2RTY4-1

Frequencies

GnomAD3 genomes
AF:
0.000598
AC:
91
AN:
152200
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00217
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000147
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.000139
AC:
35
AN:
250984
Hom.:
0
AF XY:
0.0000958
AC XY:
13
AN XY:
135644
show subpopulations
Gnomad AFR exome
AF:
0.00197
Gnomad AMR exome
AF:
0.0000290
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000176
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000780
AC:
114
AN:
1461484
Hom.:
0
Cov.:
31
AF XY:
0.0000784
AC XY:
57
AN XY:
727042
show subpopulations
Gnomad4 AFR exome
AF:
0.00260
Gnomad4 AMR exome
AF:
0.0000448
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.0000189
Gnomad4 OTH exome
AF:
0.0000662
GnomAD4 genome
AF:
0.000597
AC:
91
AN:
152318
Hom.:
0
Cov.:
32
AF XY:
0.000631
AC XY:
47
AN XY:
74482
show subpopulations
Gnomad4 AFR
AF:
0.00217
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000147
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.000172
Hom.:
0
Bravo
AF:
0.000722
ESP6500AA
AF:
0.00136
AC:
6
ESP6500EA
AF:
0.000116
AC:
1
ExAC
AF:
0.000239
AC:
29

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsOct 21, 2021The c.7150A>G (p.M2384V) alteration is located in exon 41 (coding exon 40) of the MYO9A gene. This alteration results from a A to G substitution at nucleotide position 7150, causing the methionine (M) at amino acid position 2384 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
not provided Benign:1
Likely benign, criteria provided, single submitterclinical testingInvitaeAug 15, 2018- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.050
BayesDel_addAF
Benign
-0.42
T
BayesDel_noAF
Benign
-0.39
CADD
Benign
2.0
DANN
Benign
0.65
DEOGEN2
Benign
0.015
T;T;T
Eigen
Benign
-1.3
Eigen_PC
Benign
-1.2
FATHMM_MKL
Benign
0.54
D
M_CAP
Benign
0.025
D
MetaRNN
Benign
0.0027
T;T;T
MetaSVM
Benign
-0.86
T
MutationAssessor
Benign
0.55
N;.;N
MutationTaster
Benign
1.0
N;N;N;N
PrimateAI
Benign
0.25
T
PROVEAN
Benign
-0.56
N;N;.
REVEL
Benign
0.25
Sift
Benign
0.52
T;T;.
Sift4G
Benign
0.46
T;T;T
Polyphen
0.0
B;.;B
Vest4
0.032
MVP
0.18
MPC
0.10
ClinPred
0.0047
T
GERP RS
-5.5
Varity_R
0.027
gMVP
0.13

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs147088860; hg19: chr15-72120258; API